+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Castration Resistant Prostate Cancer Drug"

Castration-resistant Prostate Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Castration-resistant Prostate Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Targeted PSMA Radionuclide Drug Conjugates Market - Global Forecast 2026-2032 - Product Thumbnail Image

Targeted PSMA Radionuclide Drug Conjugates Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Enzalutamide Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Enzalutamide Tablets Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Enzalutamide Soft Capsules Market - Global Forecast 2026-2032 - Product Thumbnail Image

Enzalutamide Soft Capsules Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Enzalutamide Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Enzalutamide Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 197 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer Pipeline Analysis Report 2025 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Metastatic Prostate Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Metastatic Castration Resistant Prostate Cancer Market - Product Thumbnail Image

Metastatic Castration Resistant Prostate Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Castration-resistant Prostate Cancer Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Castration-resistant Prostate Cancer Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Africa Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 100 Pages
  • Africa
From
Castration-resistant Prostate Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Thumbnail Image

Castration-resistant Prostate Cancer Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • December 2023
  • 180 Pages
  • Global
From
United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United States Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United States
From
United Kingdom Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Kingdom Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Kingdom
From
United Arab Emirates Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
South Korea Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

South Korea Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • South Korea
From
Saudi Arabia Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Saudi Arabia Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Saudi Arabia
From
Russia Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

Russia Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • Russia
From
India Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

India Castration-resistant Prostate Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • December 2023
  • 80 Pages
  • India
From
Loading Indicator

The Castration Resistant Prostate Cancer Drug market is a subset of the larger Prostate Cancer Drug market. It is composed of drugs that are used to treat prostate cancer that has become resistant to hormone therapy, also known as androgen deprivation therapy. These drugs are used to reduce the levels of testosterone and other hormones that can fuel the growth of prostate cancer cells. Commonly used drugs in this market include abiraterone acetate, enzalutamide, and apalutamide. The Castration Resistant Prostate Cancer Drug market is highly competitive, with many companies offering their own versions of these drugs. Some of the major players in this market include Astellas Pharma, Janssen Pharmaceuticals, Pfizer, Sanofi, and Bayer. Show Less Read more